EU says Cochlear’s Oticon poses threat to competition, will examine
EU antitrust officials cautioned that Cochlear’s acquisition of Demant poses a substantial danger. EU’s competition enforcer has adopted a more severe stance. 13 European nations had demands from the European Commission to examine the $120 million transaction. EU antitrust officials cautioned Wednesday that Australian hearing device manufacturer Cochlear’s (COH.AX) acquisition of Copenhagen-based Demant’s hearing implants … Read more